Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL. - Wikidata - awgldk - TriplyDB

Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.

Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.

http://www.wikidata.org/entity/Q35120931

about

The role of the lymphatic system in cholesterol transport Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio.Microdomains, Inflammation, and Atherosclerosis.Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits.Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis.High-density lipoprotein benefits beyond the cardiovascular system: a potential key role for modulating acquired immunity through cholesterol efflux.Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice.

P2860

Q26782973-A4CFE2C9-0CC7-4F1F-AC74-AAF8EC493602 Q28546760-2E09C540-44F2-4864-9075-ED1F9FF6795A Q35860634-AFB60774-8B54-41C1-A9CB-73AF493ED6CC Q37556042-1AA0AD34-5EE3-4F39-8EE1-71F98EB1D22E Q37623996-86E5DE9F-E4B7-423B-A684-661F44799198 Q45874236-68E7B2AD-4B54-441C-A451-B78D78A469E7 Q46347201-DBE9AD69-3FAE-4DB9-921F-F772FD7E81E5 Q52726244-9601FBC2-EC75-41E2-AC5B-483D19B37F73 Q53831751-82588887-312F-49C4-B15B-B5BA26845481 Q55437430-C8BDB164-8FB5-47B7-A9EE-991A0D28DFB8

P2860

Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.

http://www.wikidata.org/entity/Q35120931

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Macrophage apoAI protects agai ...... lerosis without affecting HDL.

@ast

Macrophage apoAI protects agai ...... lerosis without affecting HDL.

@en

type

label

Macrophage apoAI protects agai ...... lerosis without affecting HDL.

@ast

Macrophage apoAI protects agai ...... lerosis without affecting HDL.

@en

prefLabel

Macrophage apoAI protects agai ...... lerosis without affecting HDL.

@ast

Macrophage apoAI protects agai ...... lerosis without affecting HDL.

@en

P1433

Q35120931-6A8CF12D-9A5B-4108-89D7-B908F03D08B5

P1476

Q35120931-3468BEA7-D450-4292-A6DB-8DDF7D380AAF

P2093

Q35120931-151973CE-5BF2-4D9E-BE28-E976029F3EEF

Q35120931-5C10DAA1-D42D-4BCD-A520-6E2117B6E7BA

Q35120931-60785320-7FE4-4A88-A6E8-74A32B3C620C

Q35120931-61F0C5C8-0398-4487-A109-534EC70B5F05

Q35120931-6A5924D3-6E5A-4621-9968-8FB57B62EA54

Q35120931-6D0B364D-4233-456A-B602-9605E265378B

Q35120931-9846E66D-9D7D-4507-8DD2-EDCC9AFFB1B5

Q35120931-9A387A56-10D7-4F17-AC92-05398919E282

Q35120931-A964F0AE-050B-4C5B-AAB9-6E4915A52A1F

P2860

Q35120931-0012B8B5-FD24-4D07-802A-04F6F8CA7F9B

Q35120931-00B95C7E-7E93-4466-9B2C-2D220B0FCE8B

Q35120931-028D2698-CA55-49B9-90D0-63E8BBF99F89

Q35120931-165E7F18-ED01-4EB3-8082-B32F9C705EAD

Q35120931-1C50B760-DD85-4505-9589-3C5A829AF7E0

Q35120931-1CF158A7-13E2-4D5D-83C4-7386DEF1760B

Q35120931-21FF8EFD-0F3A-4396-93DE-040E2119B872

Q35120931-334D931B-C314-4C04-B23B-09122F2D6190

Q35120931-3942F902-3AE6-4AEB-BCEC-E7415BD887AE

Q35120931-3AE62D3D-12FF-4CE1-8D62-BC8607CC33C6

P304

Q35120931-0E7D02BD-A670-4396-A3FA-20F050A7C6EF

P31

Q35120931-D208630A-2B11-4F61-B719-6C97157B9FAA

P356

Q35120931-C0F87B4F-F901-48B2-8A58-29D01040F6B3

P433

Q35120931-757D2B96-2F1D-4C76-8C84-10E52DF29A8D

P478

Q35120931-51893ACE-1902-462A-9A6A-956422D50C80

P50

Q35120931-9B8B4B56-2851-4159-BCF7-054E50B2D1BC

P577

Q35120931-7A9766A4-2938-41C5-9A59-2772919D1F79

P5875

Q35120931-970819FA-2B79-4645-AC65-3CCD23404F48

P698

Q35120931-0DB2BD27-D3E1-473C-A4FD-69BC8F8E5E0A

P921

Q35120931-725883EE-7A09-45BA-A285-76D563624F25

P932

Q35120931-CD9EC7C7-C4E0-4438-A757-A2F27224422C

P356

P1433

Journal of Lipid Research

P1476

Macrophage apoAI protects agai ...... clerosis without affecting HDL

@en

P2093

Ashley J Wilhelm

http://www.w3.org/2001/XMLSchema#string

Hagai Tavori

http://www.w3.org/2001/XMLSchema#string

Ilaria Giunzioni

http://www.w3.org/2001/XMLSchema#string

John L Blakemore

http://www.w3.org/2001/XMLSchema#string

MacRae F Linton

http://www.w3.org/2001/XMLSchema#string

Manal Zabalawi

http://www.w3.org/2001/XMLSchema#string

Patricia G Yancey

http://www.w3.org/2001/XMLSchema#string

Sergio Fazio

http://www.w3.org/2001/XMLSchema#string

Yan Ru Su

http://www.w3.org/2001/XMLSchema#string

P2860

The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins

Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice

Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance?

Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies.

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study.

Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice.

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Rapid separation of lipid classes in high yield and purity using bonded phase columns.

P304

635-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M056408

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Mary G Sorci-Thomas

P577

2015-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270907549

http://www.w3.org/2001/XMLSchema#string

P698

25593328

http://www.w3.org/2001/XMLSchema#string

P921

P932

4340310

http://www.w3.org/2001/XMLSchema#string